Ruoyu Chen insider trades

Open-market stock purchases and sales by Ruoyu Chen, Chief Financial Officer at Gyre Therapeutics, Inc, from SEC Form 4 filings since Oct 31, 2023.

Recent trades

DateStockTradeValue
Jan 7, 2026GYRE Gyre Therapeutics, IncBought (not open market)—

Companies traded

  • GYRE Gyre Therapeutics, Inc: other filings, last Jan 7, 2026

Get free alerts when Ruoyu Chen files a new trade →